H1N1 vaccine arrives in B.C., but shots at least two weeks away
By Amy O’Brian and Meagan Fitzpatrick , Vancouver Sun
October 19, 2009 5:05 PM
The H1N1 vaccine has arrived in B.C., though shots are likely two weeks away.
British Columbia received its first shipment of the H1N1 vaccine over the weekend, but it will likely be another two weeks before people can start rolling up their sleeves for the shot.
The vaccine still needs Health Canada’s final approval and must still be prepared for final distribution.
Dr. Perry Kendall, B.C.’s provincial health officer, said the vaccine has to be divided into smaller lots, labelled and re-packaged, and clinics have to be organized throughout the province.
Kendall said it is unlikely the vaccine will be injected into anyone’s arm sooner than the first week of November, which is on target with national plans.
“Just having crates of vaccine doesn’t mean you can start a program,” Kendall said Monday.
“That’s the first step.”
The vaccine is being stored under tight security at the Vancouver headquarters of the BC Centre for Disease Control. Because it is already in the province, the vaccine’s distribution will be relatively fast once Health Canada authorizes its use.
Health Minister Leona Aglukkaq said Monday that Health Canada is reviewing data and once it is confident the vaccine is safe and effective, it will be released for immediate use.
Two million doses of the vaccine have been distributed to the provinces and territories so far. More doses will be shipped as they roll off the production line at GlaxoSmithKline’s factory in Quebec, where the vaccine is being manufactured.
Distributing the vaccine before its final approval is part of good planning, Aglukkaq said, and will allow the process to move more quickly than if the vaccine was shipped out only after approval was given.
The second wave of the H1N1 virus hit B.C. a couple of weeks ago, raising questions about the timeliness of the vaccine’s arrival. Eight people in B.C. have died from the flu and 78 people with lab-confirmed cases of H1N1 have been hospitalized.
Health officials in other provinces are reporting milder H1N1 activity and have yet to declare the arrival of the second wave of the flu.
Those who have had lab-confirmed cases of H1N1 are immune to the virus, but Kendall recommends everyone else get the vaccine when it becomes available.
“It won’t hurt you to get the vaccine, even if you had H1N1,” he said.
The vaccine is not a live virus, but it is composed of killed virus particles, Kendall said, and might make people feel slightly ill for up to a couple of days.
The vaccine’s adjuvant — an immune-boosting additive — could also contribute to some additional discomfort, Kendall said.
“The adjuvant causes a little bit of pain and swelling, more than you would expect with a normal flu vaccine,” he said.
“And as it produces the immune response, you can feel a little bit run down with a headache and feel some aches that last for a day or two.”
The first batch of vaccine that has been shipped out to the provinces and territories does not include any of the non-adjuvanted vaccine that has been recommended for pregnant women.
There is not a lot of clinical data on the use of adjuvanted vaccines in pregnant women and, as a result, they are advised to take a vaccine without the booster, if one is available. However, federal officials say there is no reason to believe the adjuvanted vaccine is not safe, and ordering a non-adjuvanted vaccine is a precautionary measure — one that most other countries are not taking.
It is not clear when the non-adjuvanted vaccine will be made available.
By Amy O’Brian and Meagan Fitzpatrick , Vancouver Sun
October 19, 2009 5:05 PM
The H1N1 vaccine has arrived in B.C., though shots are likely two weeks away.
British Columbia received its first shipment of the H1N1 vaccine over the weekend, but it will likely be another two weeks before people can start rolling up their sleeves for the shot.
The vaccine still needs Health Canada’s final approval and must still be prepared for final distribution.
Dr. Perry Kendall, B.C.’s provincial health officer, said the vaccine has to be divided into smaller lots, labelled and re-packaged, and clinics have to be organized throughout the province.
Kendall said it is unlikely the vaccine will be injected into anyone’s arm sooner than the first week of November, which is on target with national plans.
“Just having crates of vaccine doesn’t mean you can start a program,” Kendall said Monday.
“That’s the first step.”
The vaccine is being stored under tight security at the Vancouver headquarters of the BC Centre for Disease Control. Because it is already in the province, the vaccine’s distribution will be relatively fast once Health Canada authorizes its use.
Health Minister Leona Aglukkaq said Monday that Health Canada is reviewing data and once it is confident the vaccine is safe and effective, it will be released for immediate use.
Two million doses of the vaccine have been distributed to the provinces and territories so far. More doses will be shipped as they roll off the production line at GlaxoSmithKline’s factory in Quebec, where the vaccine is being manufactured.
Distributing the vaccine before its final approval is part of good planning, Aglukkaq said, and will allow the process to move more quickly than if the vaccine was shipped out only after approval was given.
The second wave of the H1N1 virus hit B.C. a couple of weeks ago, raising questions about the timeliness of the vaccine’s arrival. Eight people in B.C. have died from the flu and 78 people with lab-confirmed cases of H1N1 have been hospitalized.
Health officials in other provinces are reporting milder H1N1 activity and have yet to declare the arrival of the second wave of the flu.
Those who have had lab-confirmed cases of H1N1 are immune to the virus, but Kendall recommends everyone else get the vaccine when it becomes available.
“It won’t hurt you to get the vaccine, even if you had H1N1,” he said.
The vaccine is not a live virus, but it is composed of killed virus particles, Kendall said, and might make people feel slightly ill for up to a couple of days.
The vaccine’s adjuvant — an immune-boosting additive — could also contribute to some additional discomfort, Kendall said.
“The adjuvant causes a little bit of pain and swelling, more than you would expect with a normal flu vaccine,” he said.
“And as it produces the immune response, you can feel a little bit run down with a headache and feel some aches that last for a day or two.”
The first batch of vaccine that has been shipped out to the provinces and territories does not include any of the non-adjuvanted vaccine that has been recommended for pregnant women.
There is not a lot of clinical data on the use of adjuvanted vaccines in pregnant women and, as a result, they are advised to take a vaccine without the booster, if one is available. However, federal officials say there is no reason to believe the adjuvanted vaccine is not safe, and ordering a non-adjuvanted vaccine is a precautionary measure — one that most other countries are not taking.
It is not clear when the non-adjuvanted vaccine will be made available.
Comment